Fresenius Medical Care AG & Co. (FMS) Stock: What Does the Chart Say Tuesday?

Fresenius Medical Care AG & Co. (FMS) stock is up 5.21% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Fresenius Medical Care AG & Co. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on FMS!

See Full FMS Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With FMS Stock Today?

Fresenius Medical Care AG & Co. (FMS) stock is up 2.78% while the S&P 500 has fallen -1.57% as of 11:04 AM on Tuesday, Jan 18. FMS has gained $0.94 from the previous closing price of $33.80 on volume of 239,207 shares. Over the past year the S&P 500 is up 20.81% while FMS has fallen -16.13%. FMS earned $1.79 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 19.35. To see InvestorsObserver's Sentiment Score for Fresenius Medical Care AG & Co. click here.

More About Fresenius Medical Care AG & Co.

Fresenius Medical Care is the largest dialysis company in the world, treating over 345,000 patients from over 4,000 clinics across the globe as of December 2020. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line. Click Here to get the full Stock Report for Fresenius Medical Care AG & Co. stock.